COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Jeff Collins will participate in the US-India BioPharma Summit (theme: "Delivering Affordable Innovation through Cross-Border Partnerships") in Cambridge, MA
News | 06. 13. 2008
